Your browser doesn't support javascript.
loading
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M; Martin, Andrew J; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J; Tebbutt, Niall C; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David.
Affiliation
  • Lam LL; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia. integrateii.study@sydney.edu.au.
  • Pavlakis N; Royal North Shore Hospital, Sydney, Australia.
  • Shitara K; National Cancer Centre Hospital East, Chiba, Japan.
  • Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Martin AJ; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Yip S; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Kang YK; Asan Medical Centre, Seoul, South Korea.
  • Bang YJ; Seoul National University College of Medicine, Seoul, South Korea.
  • Chen LT; College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Moehler M; University Medical Centre Mainz, Mainz, Germany.
  • Bekaii-Saab T; Mayo Clinic Comprehensive Cancer Centre, Phoenix, USA.
  • Alcindor T; McGill University Health Centre, Montreal, Canada.
  • O'Callaghan CJ; Olivia Newton-John Cancer Wellness & Research Centre, Melbourne, Australia.
  • Tebbutt NC; Olivia Newton-John Cancer Wellness & Research Centre, Melbourne, Australia.
  • Hague W; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Chan H; Calvary Mater Newcastle, Waratah, Australia.
  • Rha SY; Yonsei Cancer Centre, Yonsei University Health System, Seoul, South Korea.
  • Lee KW; Seoul National University College of Medicine, Seoul, South Korea.
  • Gebski V; Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Jaworski A; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Zalcberg J; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
  • Price T; Monash University Melbourne, Melbourne, Australia.
  • Simes J; The Queen Elizabeth Hospital, Adelaide, Australia.
  • Goldstein D; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Sydney, Australia.
BMC Cancer ; 23(1): 180, 2023 Feb 22.
Article in En | MEDLINE | ID: mdl-36814222
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Guideline Limits: Adult / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms Type of study: Clinical_trials / Guideline Limits: Adult / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Australia